SGIP1 in axons prevents internalization of desensitized CB1R and modifies its function
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68378050%3A_____%2F23%3A00575884" target="_blank" >RIV/68378050:_____/23:00575884 - isvavai.cz</a>
Result on the web
<a href="https://www.frontiersin.org/articles/10.3389/fnins.2023.1213094/full" target="_blank" >https://www.frontiersin.org/articles/10.3389/fnins.2023.1213094/full</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3389/fnins.2023.1213094" target="_blank" >10.3389/fnins.2023.1213094</a>
Alternative languages
Result language
angličtina
Original language name
SGIP1 in axons prevents internalization of desensitized CB1R and modifies its function
Original language description
In the central nervous system (CNS), cannabinoid receptor 1 (CB1R) is preferentially expressed in axons where it has a unique property, namely resistance to agonist-driven endocytosis. This review aims to summarize what we know about molecular mechanisms of CB1R cell surface stability in axonal compartments, how these impact CB1R signaling, and to consider their physiological consequences. This review then focuses on a potential candidate for maintaining axonal CB1R at the cell surface, Src homology 3-domain growth factor receptor-bound 2-like endophilin interacting protein 1 (SGIP1). SGIP1 may contribute to the polarized distribution of CB1R and modify its signaling in axons. In addition, deletion of SGIP1 results in discrete behavioral changes in modalities controlled by the endocannabinoid system in vivo. Several drugs acting directly via CB1R have important therapeutic potential, however their adverse effects limit their clinical use. Future studies might reveal chemical approaches to target the SGIP1-CB1R interaction, with the aim to exploit the endocannabinoid system pharmaceutically in a discrete way, with minimized undesired consequences.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10608 - Biochemistry and molecular biology
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Frontiers in Neuroscience
ISSN
1662-453X
e-ISSN
1662-453X
Volume of the periodical
17
Issue of the periodical within the volume
Jul
Country of publishing house
CH - SWITZERLAND
Number of pages
11
Pages from-to
1213094
UT code for WoS article
001039801200001
EID of the result in the Scopus database
2-s2.0-85166532925